HEADER TRANSCRIPTION 18-JUL-08 2VY6 TITLE TWO DOMAINS FROM THE C-TERMINAL REGION OF INFLUENZA A VIRUS POLYMERASE TITLE 2 PB2 SUBUNIT COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLYMERASE BASIC PROTEIN 2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: 627- AND NLS-DOMAINS, RESIDUES 538-753; COMPND 5 SYNONYM: RNA-DIRECTED RNA POLYMERASE SUBUNIT P3, INFLUENZA A VIRUS COMPND 6 POLYMERASE PB2 SUBUNIT; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: INFLUENZA A VIRUS; SOURCE 3 ORGANISM_TAXID: 11320; SOURCE 4 STRAIN: A/VICTORIA/3/1975(H3N2); SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: AI RIL KEYWDS MRNA CAPPING, MITOCHONDRION, MRNA PROCESSING, TRANSCRIPTION, VIRAL KEYWDS 2 PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR F.TARENDEAU,T.CREPIN,D.GUILLIGAY,R.RUIGROK,S.CUSACK,D.HART REVDAT 4 13-DEC-23 2VY6 1 REMARK REVDAT 3 30-MAY-12 2VY6 1 COMPND JRNL REMARK VERSN REVDAT 3 2 1 FORMUL REVDAT 2 24-FEB-09 2VY6 1 VERSN REVDAT 1 09-SEP-08 2VY6 0 JRNL AUTH F.TARENDEAU,T.CREPIN,D.GUILLIGAY,R.RUIGROK,S.CUSACK,D.HART JRNL TITL HOST DETERMINANT RESIDUE LYSINE 627 LIES ON THE SURFACE OF A JRNL TITL 2 DISCRETE, FOLDED DOMAIN OF INFLUENZA VIRUS POLYMERASE PB2 JRNL TITL 3 SUBUNIT JRNL REF PLOS PATHOG. V. 4 136 2008 JRNL REFN ISSN 1553-7366 JRNL PMID 18769709 JRNL DOI 10.1371/JOURNAL.PPAT.1000136 REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 26.47 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 13456 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.204 REMARK 3 R VALUE (WORKING SET) : 0.201 REMARK 3 FREE R VALUE : 0.258 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 712 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.95 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.00 REMARK 3 REFLECTION IN BIN (WORKING SET) : 914 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2670 REMARK 3 BIN FREE R VALUE SET COUNT : 48 REMARK 3 BIN FREE R VALUE : 0.4030 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1555 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 76 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.43 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.16000 REMARK 3 B22 (A**2) : -1.12000 REMARK 3 B33 (A**2) : 2.22000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.85000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.194 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.179 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.144 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.993 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.945 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.908 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1582 ; 0.015 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1119 ; 0.007 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2134 ; 1.583 ; 1.968 REMARK 3 BOND ANGLES OTHERS (DEGREES): 2720 ; 0.943 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 194 ; 6.451 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 69 ;35.668 ;23.478 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 294 ;15.544 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 14 ;19.065 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 242 ; 0.088 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1722 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 321 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 309 ; 0.224 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 1171 ; 0.205 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 774 ; 0.188 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 919 ; 0.088 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 73 ; 0.181 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 18 ; 0.240 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 42 ; 0.298 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 12 ; 0.126 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1044 ; 1.189 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1575 ; 1.686 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 668 ; 2.312 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 559 ; 3.316 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2VY6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 18-JUL-08. REMARK 100 THE DEPOSITION ID IS D_1290036944. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-NOV-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 2 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.954 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14078 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.950 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : 0.13000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.9500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : 0.57000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.280 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 627-DOMAIN FROM PDB ENTRY 2VY7, AND NLS DOMAIN REMARK 200 FROM PDB ENTRY 2JDQ REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.10 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1 MICROLITRE OF 5.5 MG/ML PROTEIN REMARK 280 SOLUTION IN 10 MM TRIS-HCL PH 7.0 AND 200 MM NACL WITH EQUAL REMARK 280 VOLUME OF 100 MM HEPES PH 7.5 AND K/NA TARTRATE AT 1.2 M. REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 32.67500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 537 REMARK 465 ASP A 678 REMARK 465 PRO A 679 REMARK 465 ASP A 680 REMARK 465 GLU A 681 REMARK 465 SER A 682 REMARK 465 THR A 683 REMARK 465 SER A 684 REMARK 465 GLY A 685 REMARK 465 SER A 742 REMARK 465 ILE A 743 REMARK 465 LEU A 744 REMARK 465 THR A 745 REMARK 465 ASP A 746 REMARK 465 SER A 747 REMARK 465 GLN A 748 REMARK 465 THR A 749 REMARK 465 ALA A 750 REMARK 465 THR A 751 REMARK 465 LYS A 752 REMARK 465 ARG A 753 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 538 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 539 67.84 -109.68 REMARK 500 GLN A 728 -140.06 71.49 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2JDQ RELATED DB: PDB REMARK 900 C-TERMINAL DOMAIN OF INFLUENZA A VIRUS POLYMERASE PB2 SUBUNIT IN REMARK 900 COMPLEX WITH HUMAN IMPORTIN ALPHA5 REMARK 900 RELATED ID: 2VQZ RELATED DB: PDB REMARK 900 STRUCTURE OF THE CAP-BINDING DOMAIN OF INFLUENZA VIRUS POLYMERASE REMARK 900 SUBUNIT PB2 WITH BOUND M7GTP REMARK 900 RELATED ID: 2VY7 RELATED DB: PDB REMARK 900 THE 627-DOMAIN FROM INFLUENZA A VIRUS POLYMERASE PB2 SUBUNIT REMARK 900 RELATED ID: 2VY8 RELATED DB: PDB REMARK 900 THE 627-DOMAIN FROM INFLUENZA A VIRUS POLYMERASE PB2 SUBUNIT WITH REMARK 900 GLU-627 DBREF 2VY6 A 537 537 PDB 2VY6 2VY6 537 537 DBREF 2VY6 A 538 753 UNP P31345 PB2_I75A3 538 753 SEQRES 1 A 217 GLY GLU ILE ASN GLY PRO GLU SER VAL LEU VAL ASN THR SEQRES 2 A 217 TYR GLN TRP ILE ILE ARG ASN TRP GLU THR VAL LYS ILE SEQRES 3 A 217 GLN TRP SER GLN ASN PRO THR MET LEU TYR ASN LYS MET SEQRES 4 A 217 GLU PHE GLU PRO PHE GLN SER LEU VAL PRO LYS ALA ILE SEQRES 5 A 217 ARG GLY GLN TYR SER GLY PHE VAL ARG THR LEU PHE GLN SEQRES 6 A 217 GLN MET ARG ASP VAL LEU GLY THR PHE ASP THR THR GLN SEQRES 7 A 217 ILE ILE LYS LEU LEU PRO PHE ALA ALA ALA PRO PRO LYS SEQRES 8 A 217 GLN SER ARG MET GLN PHE SER SER LEU THR VAL ASN VAL SEQRES 9 A 217 ARG GLY SER GLY MET ARG ILE LEU VAL ARG GLY ASN SER SEQRES 10 A 217 PRO VAL PHE ASN TYR ASN LYS THR THR LYS ARG LEU THR SEQRES 11 A 217 ILE LEU GLY LYS ASP ALA GLY THR LEU ILE GLU ASP PRO SEQRES 12 A 217 ASP GLU SER THR SER GLY VAL GLU SER ALA VAL LEU ARG SEQRES 13 A 217 GLY PHE LEU ILE LEU GLY LYS GLU ASP ARG ARG TYR GLY SEQRES 14 A 217 PRO ALA LEU SER ILE ASN GLU LEU SER ASN LEU ALA LYS SEQRES 15 A 217 GLY GLU LYS ALA ASN VAL LEU ILE GLY GLN GLY ASP VAL SEQRES 16 A 217 VAL LEU VAL MET LYS ARG LYS ARG ASP SER SER ILE LEU SEQRES 17 A 217 THR ASP SER GLN THR ALA THR LYS ARG FORMUL 2 HOH *76(H2 O) HELIX 1 1 ASN A 540 ASN A 556 1 17 HELIX 2 2 ASN A 556 ASN A 567 1 12 HELIX 3 3 ASN A 567 ASN A 573 1 7 HELIX 4 4 LYS A 574 GLU A 576 5 3 HELIX 5 5 PHE A 577 VAL A 584 1 8 HELIX 6 6 ILE A 588 VAL A 606 1 19 HELIX 7 7 ASP A 611 LEU A 619 1 9 HELIX 8 8 PRO A 620 ALA A 624 5 5 HELIX 9 9 ASP A 701 GLY A 705 5 5 HELIX 10 10 ASN A 711 LEU A 716 5 6 SHEET 1 AA 2 SER A 635 VAL A 640 0 SHEET 2 AA 2 SER A 643 LEU A 648 -1 O SER A 643 N VAL A 640 SHEET 1 AB 3 PHE A 656 TYR A 658 0 SHEET 2 AB 3 ARG A 664 ILE A 667 -1 O THR A 666 N ASN A 657 SHEET 3 AB 3 LYS A 670 THR A 674 -1 O LYS A 670 N ILE A 667 SHEET 1 AC 4 PHE A 694 LYS A 699 0 SHEET 2 AC 4 ASP A 730 LYS A 736 -1 O LEU A 733 N LEU A 697 SHEET 3 AC 4 LYS A 721 GLY A 727 -1 O ALA A 722 N VAL A 734 SHEET 4 AC 4 LEU A 708 SER A 709 1 O LEU A 708 N LEU A 725 CRYST1 33.380 65.350 45.540 90.00 91.99 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.029958 0.000000 0.001041 0.00000 SCALE2 0.000000 0.015302 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021972 0.00000